<p><a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1810482/open_sms">We love to hear from our listeners. Send us a message.</a></p><p>Orca Bio&apos;s CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell &amp; Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. They cover Orca Bio&apos;s plan to potentially lowering the risk of GvHD as well as Orca-T, the investigational high-precision allogeneic cell therapy being evaluated in clinical trials for the treatment of multiple hematologic malignancies.</p>

Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.